Richard Torbett

MBE - Chief Executive @ABPI_UK Trustee @OHEnews

[ABPI @ABPI_UK]

Our Chief Executive @TorbettR gave evidence to @CommonsSITC on life sciences investment today.

He set out the problems with the medicines clawback scheme called VPAG, and why it is holding back investment in the UK by companies.

[ABPI @ABPI_UK]

The UK is losing its share of global R&D investment - as @TorbettR told @CommonsSITC earlier.

Our Competitiveness Framework made this clear. Read it here: https://t.co/rcAQS4DzZa

[ABPI @ABPI_UK]

The previous review of the medicines clawback scheme called VPAG ended without agreement with govt, but it's too important not to try again, according to our Chief Exec @TorbettR @CommonsSITC

[ABPI @ABPI_UK]

🚨Out today: our manifesto to unlock Scotland’s full potential in life sciences & innovation. 🧬

@TorbettR: With the right policy choices, Scotland can become a powerhouse for discovery, development & delivery of medicines, vaccines & diagnostics.

More: https://t.co/IeDqYhJ2kk

[ABPI @ABPI_UK]

Our Chief Executive @TorbettR was on @BBCPM earlier talking about why we have been unable to reach agreement with government in our talks reviewing the medicines rebate scheme.

Listen below and read our statement here https://t.co/5BRXbLuSWQ

[ABPI @ABPI_UK]

Vaccines and medicines are important in prevention. Uptake of new medicines in the UK is around half the average of other countries including France and Germany. Our President Russell Abberley highlights the opportunity for patients if we can change this. #NHSConfedExpo25

[Richard Torbett @TorbettR]

Really enjoyed today’s panel at #NHSconfedexpo

[ABPI @ABPI_UK]

About to start - our session in ensuring patients get the treatments they need - join us at #NHSConfedExpo with @swoolnough @TorbettR @_SarahSleet and Dr Kiren Collison of @NHSEngland

[ABPI @ABPI_UK]

The UK spends less money on medicines than other countries, and we need to think holistically about the benefits that can be achieved from them to help improve people’s health, says @TorbettR #NHSConfedExpo

[Richard Torbett @TorbettR]

Thank you @wesstreeting for being with us at our @ABPI_UK conference yesterday. Brilliant way to round off our event and the productive discussions we’ve had all week. Count on our total commitment to support your vision for health and growth in the UK

[Wes Streeting @wesstreeting]

The UK’s life science sector is central to our missions to drive economic growth and a healthier nation.

Having hosted global leaders with the PM in Downing Street, it was great to round off the week with @ABPI_UK to underscore our commitment to deliver on our shared ambitions.

[ABPI @ABPI_UK]

The @DHSCgovuk is set to demand a third of pharmaceutical company revenue in the second half of 2025 through the Statutory Scheme.

https://t.co/JKAOnxMNUT

[ABPI @ABPI_UK]

Achieving life sciences sector growth requires falling VPAG payment rates.

In this piece, @TorbettR explains the drivers behind the UK's historic underinvestment in medicine and the unprecedented opportunity to address the issue in 2025.
https://t.co/80EeTt9eAX

[Richard Torbett @TorbettR]

It was great to see @jreynoldsMP yesterday with other representatives of the UK’s leading manufacturing sectors to discuss the challenges our members face and the vast opportunity the Industrial Strategy has to drive UK growth and investment.
@ABPI_UK, @ADSgroupUK, @See_Chem_Bus, @Foodanddrinkfed, @SMMT, @biztradegovuk

[Richard Torbett @TorbettR]

A really important and worrying observation!

[Mike Rea @ideapharma]

I suspect many in the US have not really noticed this gradual but dramatic shift - even in our sphere, the number of companies asking about US-only launches is now regular

[Richard Torbett @TorbettR]

@harry_qp Hi Harry long time no see but many congratulations on your appointment. You’ll be brilliant!

[Richard Torbett @TorbettR]

‘Game-changing’ study of blood proteins will help fight disease >> really exciting project based at UK Biobank backed by 14 pharmaceutical companies #UKLifeSciences

https://t.co/m15RugL8LR

[ABPI @ABPI_UK]

Next up in our Christmas celebration of medical developments...🎄

The rollout of the RSV vaccine is the highlight of the year for @NHSEngland's Medical Director, Prof Sir Stephen Powis.

Find out why the RSV vaccine is so important: https://t.co/wBFu6T1zP5

#OurCommonGoal @NHSEnglandNMD @DHSCgovuk

[healthandcare.scot @hacscot]

“We look forward to the network of new centres working closely with industry to offer more patients across the UK the opportunity to participate in studies with cutting-edge treatments.” @TorbettR

@ABPI_UK @NHSResearchScot @UofGRegiusAnna @neilcgray
https://t.co/YCX9kRfJhE

[Pfizer UK @Pfizer_UK]

We share a common goal: Lives Lived Well.
Creating a medicine is a lengthy and complex process. Everyone involved shares the focus of improving health outcomes for patients.
Find out more at https://t.co/5OZVK4559R
@ABPI_UK #RealPfizer #OurCommonGoal

[ABPI @ABPI_UK]

In our celebration of breakthroughs of 2024, Dr June Raine of @MHRAgovuk highlights innovative regulation.

A legislative change will allow innovative products manufactured at or close to the location where a patient receives care. 🧬💊

Find out more: https://t.co/2tt0czJHBq

#OurCommonGoal

[ABPI @ABPI_UK]

🚨Our latest annual report on UK industry clinical trials is out! A mixed review:

☑️The overall number of trials is up for the second year in a row
❎ Participants in interventional trials are down

We have 6⃣ recommendations for improvement. Read more: https://t.co/bwJmUs7fMz